p. 1-10The first- and second-trimester screening for trisomy 21 (T21) are reimbursed for all pregnant women in Belgium. Using a cut-off risk of 1:300 for T21, about 5% of all pregnant women are referred for definitive prenatal diagnosis using an invasive test, at a sensitivity of (only) 72.5%. The sensitivity and specificity of the non-invasive prenatal test (NIPT) are over 99% but come at a cost of €460 (£373) per test. The objective is to estimate the consequences of introducing NIPT for the detection of T21. METHODS: A cost-consequences analysis was performed presenting the impact on benefits, harms and costs. Context-specific real-world information was available to set up a model reflecting the current screening situation in Belgium. Th...
Objectives: In most countries, non-invasive prenatal testing (NIPT) has been introduced commercially...
Non-invasive prenatal testing (NIPT) for Down's syndrome (DS) using cell free fetal DNA in maternal ...
Objectives: In most countries, non-invasive prenatal testing (NIPT) has been introduced commercially...
p. 1-10The first- and second-trimester screening for trisomy 21 (T21) are reimbursed for all pregnan...
p. 21Modelling of NIPT Figure 3 presents an overview of the current screening strategy in Belgium. I...
Item does not contain fulltextOBJECTIVE: Non-invasive prenatal testing (NIPT) using cell-free fetal ...
106 p.ill,SCIENTIFIC REPORT 8 -- 1 COST-EFFECTIVENESS OF NIPT 8 -- 1.1 RESEARCH QUESTIONS AND METHOD...
© 2017 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists Background: ...
1347-1352BACKGROUND: Several countries today struggle with suboptimal performances in many aspects o...
Objective To evaluate the clinical impact of nationwide implementation of genome-wide non-invasive p...
To evaluate the clinical impact of nationwide implementation of genome-wide non-invasive prenatal te...
Non-invasive prenatal testing (NIPT) for Down’s syndrome (DS) using cell free fetal DNA in maternal ...
Background: Non-invasive prenatal testing (NIPT) for Down’s syndrome (DS) using cell free fetal DNA ...
OBJECTIVE: To evaluate the clinical impact of nationwide implementation of genome-wide Non-Invasive ...
textabstractObjective: To evaluate the clinical impact of nationwide implementation of genome-wide n...
Objectives: In most countries, non-invasive prenatal testing (NIPT) has been introduced commercially...
Non-invasive prenatal testing (NIPT) for Down's syndrome (DS) using cell free fetal DNA in maternal ...
Objectives: In most countries, non-invasive prenatal testing (NIPT) has been introduced commercially...
p. 1-10The first- and second-trimester screening for trisomy 21 (T21) are reimbursed for all pregnan...
p. 21Modelling of NIPT Figure 3 presents an overview of the current screening strategy in Belgium. I...
Item does not contain fulltextOBJECTIVE: Non-invasive prenatal testing (NIPT) using cell-free fetal ...
106 p.ill,SCIENTIFIC REPORT 8 -- 1 COST-EFFECTIVENESS OF NIPT 8 -- 1.1 RESEARCH QUESTIONS AND METHOD...
© 2017 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists Background: ...
1347-1352BACKGROUND: Several countries today struggle with suboptimal performances in many aspects o...
Objective To evaluate the clinical impact of nationwide implementation of genome-wide non-invasive p...
To evaluate the clinical impact of nationwide implementation of genome-wide non-invasive prenatal te...
Non-invasive prenatal testing (NIPT) for Down’s syndrome (DS) using cell free fetal DNA in maternal ...
Background: Non-invasive prenatal testing (NIPT) for Down’s syndrome (DS) using cell free fetal DNA ...
OBJECTIVE: To evaluate the clinical impact of nationwide implementation of genome-wide Non-Invasive ...
textabstractObjective: To evaluate the clinical impact of nationwide implementation of genome-wide n...
Objectives: In most countries, non-invasive prenatal testing (NIPT) has been introduced commercially...
Non-invasive prenatal testing (NIPT) for Down's syndrome (DS) using cell free fetal DNA in maternal ...
Objectives: In most countries, non-invasive prenatal testing (NIPT) has been introduced commercially...